Patent assignee · FR · UNIVERSITY

Université Paris—Est Créteil Val de Marne

34Patents
34Active
34Granted
54Portfolio score

Filing activity: Sep 10, 2009 → Dec 16, 2021 · 3 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9233144B2 Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer Physics 2 Active
US9097728B2 Method for diagnosing a hemoglobin-related disorder Physics 1 Active
US11231427B2 Method for determining the haemoglobin F content of an erythroid cell Physics 1 Active
US10322162B2 Methods and pharmaceutical compositions for the treatment of ischemic conditions Chemistry; Metallurgy 0 Active
US10724095B2 Diagnostic markers of immunosenescence and methods for determining the susceptibility to nosocomial infections Physics 0 Active
US11841306B2 Fine particle sensor with cascaded microscales Physics 0 Active
US12350062B2 Analysis system with a portable connected device Human Necessities 0 Active
US11906520B2 Composition and methods for detecting cancer Physics 0 Active
US9402821B2 Methods and pharmaceutical compositions for treatment of cystic fibrosis Human Necessities 0 Active
US12345718B2 Method for determining the haemoglobin content of an erythroid cell Physics 0 Active
US9504732B2 Methods for treating myocardial infarction comprising administering sonic hedgehog Chemistry; Metallurgy 0 Active
US9804172B2 Soluble ST2 as a marker for risk of mortality in HIV-infected subjects Physics 0 Active
US9944669B2 Fumarate-CO-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation Chemistry; Metallurgy 0 Active
US10722572B2 Methods and compositions for treating and preventing HIV Chemistry; Metallurgy 0 Active
US10548980B2 P2X7 receptor antagonists for restoring T-cell lymphopoiesis in subjects infected with human immunodeficiency virus (HIV) Human Necessities 0 Active
US10519179B2 Highly efficient NRF2 activators-co-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation Chemistry; Metallurgy 0 Active
US8932599B2 Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccines Chemistry; Metallurgy 0 Active
US11670798B2 Solid electrolyte for a lithium-ion electrochemical cell Emerging Cross-Sectional Technologies 0 Active
US11928958B2 Method and device for guiding using a connected object in a building Physics 0 Active
US11219683B2 Methods and compositions for treating and preventing HIV Chemistry; Metallurgy 0 Active
US12083271B2 Liquid ventilator and method to induce tidal liquid ventilation and/or hyporthermia Human Necessities 0 Active
US11821060B2 Superalloy with optimized properties and a limited density Chemistry; Metallurgy 0 Active
US11359027B2 Prevention or treatment of hematologic malignancy relapse using a TNFR2 antagonist Chemistry; Metallurgy 0 Active
US9494603B2 Method for diagnosing a hemoglobin-related disorder Physics 0 Active
US9987327B2 Methods for treating myocardial infarction comprising administering sonic hedgehog Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.